Gustavo A. Rosario Benitez

Array ( [id] => 6616652 [patent_doc_number] => 20100003256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Use of TGF-Beta Antagonists in Treatment of Parathyroid-Related Disorders' [patent_app_type] => utility [patent_app_number] => 12/315812 [patent_app_country] => US [patent_app_date] => 2007-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12833 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003256.pdf [firstpage_image] =>[orig_patent_app_number] => 12315812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9964524 [patent_doc_number] => 09012134 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-21 [patent_title] => 'CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ Tregs' [patent_app_type] => utility [patent_app_number] => 11/756479 [patent_app_country] => US [patent_app_date] => 2007-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 14 [patent_no_of_words] => 26655 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11756479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10033732 [patent_doc_number] => 09075044 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Compositions and methods for detection and modulation of T cell mediated immune responses against viral vectors utilized for gene therapy' [patent_app_type] => utility [patent_app_number] => 12/302206 [patent_app_country] => US [patent_app_date] => 2007-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 20 [patent_no_of_words] => 7330 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12302206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4759373 [patent_doc_number] => 20080311599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'ANTIBODIES AGAINST CASPASE-8, THEIR PREPARATION AND USE' [patent_app_type] => utility [patent_app_number] => 11/745949 [patent_app_country] => US [patent_app_date] => 2007-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16122 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311599.pdf [firstpage_image] =>[orig_patent_app_number] => 11745949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367098 [patent_doc_number] => 20090304657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'CHIMERIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/298927 [patent_app_country] => US [patent_app_date] => 2007-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 21964 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304657.pdf [firstpage_image] =>[orig_patent_app_number] => 12298927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501646 [patent_doc_number] => 20090162334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'PRODUCTION AND USE OF REGULATORY T CELLS' [patent_app_type] => utility [patent_app_number] => 12/298323 [patent_app_country] => US [patent_app_date] => 2007-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7086 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162334.pdf [firstpage_image] =>[orig_patent_app_number] => 12298323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391158 [patent_doc_number] => 20090208471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Isolation and Use of Human Regulatory T Cells' [patent_app_type] => utility [patent_app_number] => 12/296386 [patent_app_country] => US [patent_app_date] => 2007-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13333 [patent_no_of_claims] => 175 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208471.pdf [firstpage_image] =>[orig_patent_app_number] => 12296386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5354673 [patent_doc_number] => 20090186017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'Graft-Versus-Host Disease Predicting Marker and Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/296345 [patent_app_country] => US [patent_app_date] => 2007-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8345 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186017.pdf [firstpage_image] =>[orig_patent_app_number] => 12296345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5027979 [patent_doc_number] => 20070269426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Use of Soluble Gammadelta Cell Receptors for Regulating T Cell Function' [patent_app_type] => utility [patent_app_number] => 11/695986 [patent_app_country] => US [patent_app_date] => 2007-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18284 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20070269426.pdf [firstpage_image] =>[orig_patent_app_number] => 11695986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6340130 [patent_doc_number] => 20100247555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'REVERSIBLY INHIBITED ANTIBODIES FOR IMMUNE CELL STIMULATION' [patent_app_type] => utility [patent_app_number] => 12/293747 [patent_app_country] => US [patent_app_date] => 2007-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8496 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247555.pdf [firstpage_image] =>[orig_patent_app_number] => 12293747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7489810 [patent_doc_number] => 08030005 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-04 [patent_title] => 'Method for detecting antigen specific or mitogen-activated T cells' [patent_app_type] => utility [patent_app_number] => 12/293222 [patent_app_country] => US [patent_app_date] => 2007-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 10621 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/030/08030005.pdf [firstpage_image] =>[orig_patent_app_number] => 12293222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063753 [patent_doc_number] => 20110245153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Neutralizing Agents for Bacterial Toxins' [patent_app_type] => utility [patent_app_number] => 12/282193 [patent_app_country] => US [patent_app_date] => 2007-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 35519 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245153.pdf [firstpage_image] =>[orig_patent_app_number] => 12282193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5062552 [patent_doc_number] => 20070224191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Methods of treatment of Ulcerative Colitis and Crohn\'s disease with anti-CD3 antibodies' [patent_app_type] => utility [patent_app_number] => 11/713465 [patent_app_country] => US [patent_app_date] => 2007-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18935 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20070224191.pdf [firstpage_image] =>[orig_patent_app_number] => 11713465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5177033 [patent_doc_number] => 20070178093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'LYMPHOCYTES; METHODS' [patent_app_type] => utility [patent_app_number] => 11/675190 [patent_app_country] => US [patent_app_date] => 2007-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11369 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20070178093.pdf [firstpage_image] =>[orig_patent_app_number] => 11675190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4490945 [patent_doc_number] => 07955598 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-07 [patent_title] => 'Therapeutic agent for chronic arthritides diseases of childhood-related diseases' [patent_app_type] => utility [patent_app_number] => 11/704233 [patent_app_country] => US [patent_app_date] => 2007-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12201 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/955/07955598.pdf [firstpage_image] =>[orig_patent_app_number] => 11704233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4568019 [patent_doc_number] => 07829097 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-09 [patent_title] => 'Use of HMGB1 for protection against ischemia reperfusion injury' [patent_app_type] => utility [patent_app_number] => 11/671932 [patent_app_country] => US [patent_app_date] => 2007-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 9184 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/829/07829097.pdf [firstpage_image] =>[orig_patent_app_number] => 11671932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5004537 [patent_doc_number] => 20070202105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'DOMAIN ANTIBODY CONSTRUCT' [patent_app_type] => utility [patent_app_number] => 11/670261 [patent_app_country] => US [patent_app_date] => 2007-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13006 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202105.pdf [firstpage_image] =>[orig_patent_app_number] => 11670261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5004517 [patent_doc_number] => 20070202085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Systems and methods for monitoring immune responses and predicting outcomes in transplant recipients' [patent_app_type] => utility [patent_app_number] => 11/653743 [patent_app_country] => US [patent_app_date] => 2007-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15683 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202085.pdf [firstpage_image] =>[orig_patent_app_number] => 11653743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 169781 [patent_doc_number] => 07662379 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Interleukin-10 antibodies' [patent_app_type] => utility [patent_app_number] => 11/623006 [patent_app_country] => US [patent_app_date] => 2007-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 8 [patent_no_of_words] => 20979 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662379.pdf [firstpage_image] =>[orig_patent_app_number] => 11623006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545434 [patent_doc_number] => 20090155311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'INDOLEAMINE 2,3-DIOXYGENASE PATHWAYS IN THE GENERATION OF REGULATORY T CELLS' [patent_app_type] => utility [patent_app_number] => 12/158170 [patent_app_country] => US [patent_app_date] => 2007-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 25583 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155311.pdf [firstpage_image] =>[orig_patent_app_number] => 12158170 [rel_patent_id] =>[rel_patent_doc_number] =>)